Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.
about
Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.The kinesin Eg5 inhibitor K858 induces apoptosis and reverses the malignant invasive phenotype in human glioblastoma cells.Differential Expression and Clinical Significance of Transforming Growth Factor-Beta Isoforms in GBM Tumors.
P2860
Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Blocking epithelial-to-mesench ...... rposed drugs: the EIS regimen.
@en
type
label
Blocking epithelial-to-mesench ...... rposed drugs: the EIS regimen.
@en
prefLabel
Blocking epithelial-to-mesench ...... rposed drugs: the EIS regimen.
@en
P2093
P2860
P356
P1433
P1476
Blocking epithelial-to-mesench ...... rposed drugs: the EIS regimen.
@en
P2093
Georg Karpel-Massler
Marc-Eric Halatsch
Nicolas Skuli
Richard E Kast
Timothy Ryken
P2860
P304
60727-60749
P356
10.18632/ONCOTARGET.18337
P407
P577
2017-06-01T00:00:00Z